RU-486 also known as Mifepristone is a controversial issue in America. RU-486 provides women with an alternative option to surgical abortion. The Food and Drug Administration approved Mifepristone in the United States on September 28, 2000. When the Food and Drug Administration approved the use of Mifepristone for use in the United States, it did not limit its distribution to only doctors that already perform abortions, nor did it require a doctor to complete any training to distribute the drug. Any doctor who is able to establish the date of the pregnancy conclusively and provide surgical intervention in the event that something goes wrong, may write a prescription for and administer Mifepristone.
             RU-486 is a non-surgical abortion. It must be used in the first seven weeks of pregnancy. RU-486 was originally produced and marketed in France by Roussel Uclaf debuting in 1988. RU-486 is also known as Mifepristone. In order for a woman to be able to use RU-486 she must first visit an approved clinic for a physical examination and pregnancy test. Her medical history is screened to determine if there is any reason why the drug should not be used in her situation. At this point she is given RU-486 in tablet form and swallows them in the presence of a nurse or doctor before leaving the clinic. A woman usually begins to bleed the day after taking RU-486.
             A woman must return to the clinic after forty-eight hours to receive the prostaglandin, which will complete the abortion. The woman stays at the clinic for the next four to six hours. Most abort there and the rest will abort at ****. A woman must return several days later for a physician's examination to make sure the abortion is complete and to determine if she has experienced any side effects. In other words RU-486 takes longer than a surgical abortion, however if the non-surgical abortion fails the pat
             ...